Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CJC-1134-PC in Type 2 Diabetes on Metformin
CTR20170588Phase 2Completed
- Sponsor
- Changshan Biochemical Pharmaceutical
- Start
- Aug 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of albenatide in type 2 diabetes mellitus (T2DM), sponsored by Changshan Biochemical Pharmaceutical. Started Aug 2017; status: completed.
02
Drugs
albenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20170588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170588.